Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review.

Copeland J, Pokorski I.

Subst Abuse Rehabil. 2016 May 3;7:41-53. doi: 10.2147/SAR.S89857. eCollection 2016 May 3. Review.

PMID:
27217809
2.

Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study.

Maple KE, McDaniel KA, Shollenbarger SG, Lisdahl KM.

Am J Drug Alcohol Abuse. 2016 Jul;42(4):431-40. doi: 10.3109/00952990.2016.1141913. Epub 2016 Apr 13.

PMID:
27074158
3.

Medical Marijuana Legalization and Co-use in Adult Cigarette Smokers.

Wang JB, Cataldo JK.

Am J Health Behav. 2016 Mar;40(2):205-14. doi: 10.5993/AJHB.40.2.5.

PMID:
26931752
4.

Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder.

Kim SW, Dodd S, Berk L, Kulkarni J, de Castella A, Fitzgerald PB, Kim JM, Yoon JS, Berk M.

Psychiatry Investig. 2015 Jul;12(3):349-55. doi: 10.4306/pi.2015.12.3.349. Epub 2015 Jul 6.

PMID:
26207128
5.

Endocannabinoid signaling in the etiology and treatment of major depressive illness.

Hillard CJ, Liu QS.

Curr Pharm Des. 2014;20(23):3795-811. Review.

PMID:
24180398
6.

Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.

Hillard CJ, Weinlander KM, Stuhr KL.

Neuroscience. 2012 Mar 1;204:207-29. doi: 10.1016/j.neuroscience.2011.11.020. Epub 2011 Nov 17. Review.

PMID:
22123166
7.

Cannabis and psychopathology : update 2004.

Grover S, Basu D.

Indian J Psychiatry. 2004 Oct;46(4):299-309.

PMID:
21206788
8.

Role of endocannabinoid signaling in anxiety and depression.

Patel S, Hillard CJ.

Curr Top Behav Neurosci. 2009;1:347-71. doi: 10.1007/978-3-540-88955-7_14.

PMID:
21104391
9.

Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative.

de Graaf R, Radovanovic M, van Laar M, Fairman B, Degenhardt L, Aguilar-Gaxiola S, Bruffaerts R, de Girolamo G, Fayyad J, Gureje O, Haro JM, Huang Y, Kostychenko S, L├ępine JP, Matschinger H, Mora ME, Neumark Y, Ormel J, Posada-Villa J, Stein DJ, Tachimori H, Wells JE, Anthony JC.

Am J Epidemiol. 2010 Jul 15;172(2):149-59. doi: 10.1093/aje/kwq096. Epub 2010 Jun 9.

PMID:
20534820
10.

Substance misuse and psychiatric illness: prospective observational study using the general practice research database.

Frisher M, Crome I, Macleod J, Millson D, Croft P.

J Epidemiol Community Health. 2005 Oct;59(10):847-50.

PMID:
16166357
11.

Comparing cannabis with tobacco.

Henry JA, Oldfield WL, Kon OM.

BMJ. 2003 May 3;326(7396):942-3. No abstract available.

PMID:
12727737

Supplemental Content

Support Center